Radiofrequency Ablation for Polymorphic Ventricular Tachycardia With Heart Failure (RFCA for PMVT-HF)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 118 participants.

Also called NCT07130175

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 118 participants (enrolled count) (from the registry)
Sponsor
Qian Feng (from the registry)
Registry
  • NCT NCT07130175
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07130175. Randomized; no masking; primary purpose treatment. Start 2022-12-31 (actual); primary completion 2024-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Radiofrequency Ablation for Polymorphic Ventricular Tachycardia With Heart Failure (RFCA for PMVT-HF)
Condition
Polymorphic Ventricular Tachycardia
Condition
Heart Failure
Intervention (Device)
Radiofrequency Catheter Ablation
Intervention (Drug)
Guideline-Directed Medical Therapy (GDMT)
Lead sponsor
Qian Feng (class: other)
Collaborator
The First Hospital of Zhangjiakou City (class: not stated)

Record details

Record id
cardio:ct-nct07130175
Content hash
0c2294846ee7ed71efbb290e9360fe8f1bc5c2fb010ae00ed20dd4c82f32b823